Physician profile
Marie Thomas
NPI 1174992416
$2,154.35
in general payments reported to CMS, 2019-2025
16 companies · $76.78 in 2025
The $76.78 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $433 · 2022: $516 · 2023: $720 · 2024: $409 · 2025: $76.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,205.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $612.97 | 2021-2025 | |
| Amgen INC. | $425.45 | 2021-2024 | Repatha, Otezla, Prolia |
| Lilly USA, LLC | $350.28 | 2021-2024 | Mounjaro, Zepbound, Emgality |
| Novo Nordisk INC | $277.97 | 2021-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $101.81 | 2021-2024 | Breztri |
| Glaxosmithkline, LLC. | $68.80 | 2023 | Trelegy Ellipta |
| Pfizer INC. | $60.62 | 2023-2024 | |
| Teva Pharmaceuticals USA, INC. | $56.87 | 2021-2023 | Ajovy |
| Amarin Pharma, INC. | $41.39 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $28.36 | 2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.64 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.46 | 2022 | |
| Leo Pharma INC. | $21.83 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $21.82 | 2022 | |
| Esperion Therapeutics, INC. | $20.87 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $18.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.